Literature DB >> 2366877

Evidence for an extraneuronal location of monoamine oxidase in renal tissues.

M M Caramona1, P Soares-da-Silva.   

Abstract

(1) Homogenates of renal cortex and renal medulla of control and 6-hydroxydopamine-denervated cat kidneys were prepared. (2) Monoamine oxidase (MAO) activity was determined with [3H]-5-hydroxytryptamine [( 3H]-5HT) and [14C]-beta-phenylethylamine [( 14C]-beta-PEA) as preferential substrates for MAO-A and MAO-B, respectively. (3) The endogenous dopamine and noradrenaline tissue contents of control and chemically-denervated kidneys were compared with the MAO activities. (4) The results show that a 70% depletion of monoamine content by chemical denervation resulted only in a 23% reduction of MAO-A activity in the renal cortex, whereas MAO-B was unaffected either in the cortical or the medullary zones; in the renal medulla MAO-A activity was not changed by denervation. Most of the MAO activity in the cat kidney is of the B type (74%) and is located in the renal cortex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2366877     DOI: 10.1007/bf00176332

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

3.  Monoamine oxidase in rat arteries: evidence for different forms and selective localization.

Authors:  J F Coquil; C Goridis; G Mack; N H Neff
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

4.  Occurrence and properties of monoamine oxidase in adrenergic neurons.

Authors:  B Jarrott
Journal:  J Neurochem       Date:  1971-01       Impact factor: 5.372

5.  Localization of monoamine oxidase of type A and B in blood vessels with different innervation patterns.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

6.  Effect of chronic denervation on the activities of monoamine oxidase and catechol-O-methyl transferase and on the contents of noradrenaline and adenosine triphosphate in the rabbit ear artery.

Authors:  R J Head; R E Stitzel; I S de la Lande; S M Johnson
Journal:  Blood Vessels       Date:  1977

Review 7.  Synthesis and metabolism of dopamine in the kidney. Effects of sodium chloride, monoamine oxidase inhibitors and alpha-human atrial natriuretic peptide.

Authors:  P Soares-da-Silva; M H Fernandes
Journal:  Am J Hypertens       Date:  1990-06       Impact factor: 2.689

8.  Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

9.  Further evidence for a noradrenaline-independent storage of dopamine in the dog kidney.

Authors:  P Soares-da-Silva
Journal:  J Auton Pharmacol       Date:  1988-06

10.  Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.

Authors:  M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

  10 in total
  3 in total

1.  Deamination of newly-formed dopamine in rat renal tissues.

Authors:  M H Fernandes; M Pestana; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

2.  The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.

Authors:  M Pestana; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

3.  Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.

Authors:  M Pestana; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.